Intralytix Receives First Regulatory Approval
BALTIMORE, MD., JUNE 5, 2002.
Intralytix, Inc., announced today that it has received regulatory approval from the U.S. Environmental Protection Agency (EPA) for the first in a line of products designed to prevent bacterial contamination of food and food processing plants. The first product to receive an experimental use permit from the EPA is "LMP 102," a product that decontaminates food processing plants from Listeria monocytogenes.
"Listeria contamination of food is a serious and growing health risk" notes Intralytix's Chairman, Dr. Torrey Brown. "The FDA has a zero tolerance for Listeria contamination of food and, almost on a weekly basis," he added, "there are significant recalls of Listeria contaminated food products." "The EPA permit will allow Intralytix to complete efficacy studies in actual plant operations. We intend to be in commercial sales by year's end."
Dr. Brown noted that LMP 102 is the first in a series of products developed by Intralytix to decontaminate and protect food products from common bacterial contaminants such as Listeria, Salmonella, Campylobacter and E. coli 0157:H7. All of these products are based upon Bacteriophage technology. Bacteriophage or phage are natural organisms which kill bacteria. Phages are perfectly safe for humans and other living organisms, other than bacteria. "Basically," reports Dr. Brown, "Intralytix's technology permits us to identify nature's natural bacteria killers, isolate, multiply and purify them, and then put them into places where they can do the most good." "The great benefit of bacteriophage-based decontaminants" states Dr. Brown, "is that they are environmentally friendly, replace or reduce the use of caustic chemicals, reduce the over use of antibiotics and are effective against antibiotic-resistant bacteria strains."
Intralytix is the world's leading bacteriophage company. Headquartered in Baltimore, Maryland, the company is developing a broad range of bacteriophage-based products to be used for food and agricultural decontaminants, decontamination of industrial and medical facilities and veterinary and human therapeutics.
For more information, contact Dr. Alexander Sulakvelidze at 410-625-2533, or at email@example.com.
Jun 05, 2002